NOS2 and myocardial ischemia: MiR-939-5p (52) levels were notably reduced in EVs from the coronary serum of myocardial ischemia patients, enhancing angiogenesis via the miR-939-inducible nitric oxide synthase (iNOS)-NO pathways, with CMs potentially being the origin of these bioactive EVs.